BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Viswanath A, Fouda S, Fernandez CJ, Pappachan JM. Metabolic-associated fatty liver disease and sarcopenia: A double whammy. World J Hepatol 2024; 16(2): 152-163 [PMID: 38495287 DOI: 10.4254/wjh.v16.i2.152]
URL: https://www.wjgnet.com/1007-9327/full/v16/i2/152.htm
Number Citing Articles
1
Gholam Reza Sivandzadeh, Ali Shahsavari, Elahe Meftah, Ramin Niknam, Ali Reza Safarpour. Effect of L-carnitine supplementation on muscle cramps in liver cirrhosis: results from a retrospective cohort studyBMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03730-4
2
Marina Ribas Losasso, Maria Luiza Cesto Parussolo, Antony Oliveira Silva, Rosa Direito, Karina Quesada, Claudia Rucco Penteado Detregiachi, Marcelo Dib Bechara, Nahum Méndez-Sánchez, Ludovico Abenavoli, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Elen Landgraf Guiger, Lucas Fornari Laurindo, Sandra Maria Barbalho. Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and SarcopeniaInternational Journal of Molecular Sciences 2025; 26(10): 4673 doi: 10.3390/ijms26104673
3
Longshan Yang, Xiaojun Zeng. Lean-MAFLD: imperatives for updated evidence, mechanistic clarity, and methodological rigorHepatology International 2025;  doi: 10.1007/s12072-025-10832-4
4
Yilin Wen, Ping Weng, Yueyue Li, Liming Yang, Chengju Li, Qingyang Chen, Yanni He, Wanping Zhang, Hui Hu, Zhiyi Yuan, Chao Yu. Triglyceride-Targeted Molecularly Imprinted Polymers Activate Lipophagy via Cargo Exchange for Nonalcoholic Fatty Liver Disease TreatmentACS Applied Polymer Materials 2024; 6(12): 7265 doi: 10.1021/acsapm.4c01222
5
Rochelle Wong, Li-Yun Yuan. Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address bothWorld Journal of Hepatology 2024; 16(6): 871-877 doi: 10.4254/wjh.v16.i6.871